ArticleFrontiers in immunology2024

Case report: Clinical complete response in advanced ALK-positive lung squamous cell carcinoma: a case study of successful anti-PD-1 immunotherapy post ALK-TKIs failure.

Chen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.